IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia
Clinical trial NCT04599543 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04599543
- Sponsor
- Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-15
- Primary completion
- 2023-11-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.